#liver14
LightNews LightNews
livermd.bsky.social
#Achillion's NS5A inh #ACH3102+#Sovaldi data and NS5B inh #ACH3422 pre-clinical data to be presented @ #Liver14 http://ir.achillion.com/releasedetail.cfm?releaseid=875231 …
Web Site Not Found
ir.achillion.com
December 3, 2024 at 2:27 PM
livermd.bsky.social
Data for #MRK 1 pill duo of PI #Grazoprevir and NS5A inh #Elbasvir in cirrhotics/nulls/ HIV-HCV/renal dz @ #Liver14
http://bit.ly/1Eumq0G
Media - Merck.com
Merck's online newsroom offers real-time news about Merck...
bit.ly
December 3, 2024 at 2:27 PM
livermd.bsky.social
#MRK to present "ultra-short" C-SWIFT ph 2 data looking at 4 wk rx with #Grazoprevir/#Elbasvir+#Sovaldi @ #Liver14
http://bit.ly/1Eumq0G
Media - Merck.com
Merck's online newsroom offers real-time news about Merck...
bit.ly
December 3, 2024 at 2:27 PM
livermd.bsky.social
Plane chock full of "liver people" on the way from #CLE to #BOS to attend #Liver14
December 3, 2024 at 2:17 PM
livermd.bsky.social
@AASLDNews great meeting @HenryEChang @joeladler @DokterKoning @TheLiverPost @ #liver14 tweet up. Looking forward to post grad course next
December 3, 2024 at 2:17 PM
livermd.bsky.social
Dr O'farelly gives dynamic intro to inflammation &the liver incl. potential of dendritic cells in immune regulation & new vaccines #Liver14
December 3, 2024 at 2:17 PM
livermd.bsky.social
Dr. Thiele explains cytokine-mediated effect of systemic inflammation on liver bile transport leading to "cholestasis of sepsis" #Liver14
December 3, 2024 at 2:17 PM
livermd.bsky.social
Dr. Kleiner highlights similarities & differences in liver injury patterns making up basis for necroinflammation scoring systems #liver14
December 3, 2024 at 2:17 PM
livermd.bsky.social
Dr. Quigley "small intestinal bacterial overgrowth #SIBO common and has bad consequences in advanced liver disease" #Liver14
December 3, 2024 at 2:17 PM
livermd.bsky.social
Dr Quigley introduces concept of bi-directional microbiome gut liver axis. Few high quality microbiome manipulation studies caviat liver14
December 3, 2024 at 2:12 PM
livermd.bsky.social
In many years of liver meeting attendance in #BOS, I do not recall Hynes auditorium running out of lower level seats. Kudos to all #Liver14
December 3, 2024 at 2:12 PM
livermd.bsky.social
Dr. Kamath discusses systemic inflammatory response syndrome #SIRS and how it ties to acute liver failure and multi-organ failure #liver14
December 3, 2024 at 2:12 PM
livermd.bsky.social
Dr. Cox efficacy of rHEV vaccine 96% based on large Nepal clinical trial. rHEV remains cost inaccessible to those who need it most
#Liver14
December 3, 2024 at 2:11 PM
livermd.bsky.social
Dr. Lohse "biochemical remission in autoimmune hepatitis #AIH means normal ALT and IgG. Trial high dose steroids if dx in doubt" #Liver14
December 3, 2024 at 2:11 PM
livermd.bsky.social
Dr. Beuers "norUDCA is a potent stimulator of cholangiocyte bicarbonate secretion, may be promising for Primary Biliary Cirrhosis" #Liver14
December 3, 2024 at 2:11 PM
livermd.bsky.social
Dr. Beuers "Chronic exposure to environmental agents eg: solvents may drive #PBC, #PSC and #AIH in genetically susceptible people" #Liver14
December 3, 2024 at 2:11 PM
livermd.bsky.social
Dr. Fontana "autoantibodies incl. ANA not specific for #AIH and can be positive in alcoholic, non alcoholic & viral liver disease" #Liver14
December 3, 2024 at 2:11 PM
livermd.bsky.social
Dr. Feng "acute cellular rejection incidence has plummeted. Early rejection does not worsen outcomes but late does" #liver14
December 3, 2024 at 2:11 PM
livermd.bsky.social
Dr. Feng " evidence for concept of liver transplantation "clearing" donor spec. antibodies, preventing renal humoral rejection" #liver14
December 3, 2024 at 2:11 PM
livermd.bsky.social
Dr. Friedman "gut is important and targetable in fatty liver disease treatment. Liver-adipose cross talk important also key " #Liver14
December 3, 2024 at 2:06 PM
livermd.bsky.social
#AASLD Prez elect Szabo "many of the advances in #Hepatology fall in spectrum of translational research. Greatest example is #HCV" #Liver14
December 3, 2024 at 2:06 PM
livermd.bsky.social
#AASLD president elect Gyongyi Szabo "important barrier to curing liver disease is access to and affordability of therapy" #Liver14
December 3, 2024 at 2:06 PM
livermd.bsky.social
Up (really) early for EMW12 with Drs Gore & Singal.Topic is new anti-tumor agents in development for hepatocellular carcinoma #HCC #liver14
December 3, 2024 at 2:06 PM
livermd.bsky.social
Dr. Sharpton "80+ yo livers mostly originate from the eastern US. 3 yr Outcomes acceptable. Which recipients benefit best unclear" #Liver14
December 3, 2024 at 2:06 PM
livermd.bsky.social
Dr. Emond delivers Starzl Transplant Surgery state-of-the art lecture on promise and pitfalls of live donor liver transplantation #liver14
December 3, 2024 at 2:06 PM